WO2011129788A1 - Inhalateur à poudre sèche d'utilisation facile - Google Patents

Inhalateur à poudre sèche d'utilisation facile Download PDF

Info

Publication number
WO2011129788A1
WO2011129788A1 PCT/TR2011/000088 TR2011000088W WO2011129788A1 WO 2011129788 A1 WO2011129788 A1 WO 2011129788A1 TR 2011000088 W TR2011000088 W TR 2011000088W WO 2011129788 A1 WO2011129788 A1 WO 2011129788A1
Authority
WO
WIPO (PCT)
Prior art keywords
inhaler
mouthpiece cover
dry powder
mouthpiece
medicament
Prior art date
Application number
PCT/TR2011/000088
Other languages
English (en)
Inventor
Mahmut Bilgic
Original Assignee
Mahmut Bilgic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from TR2010/02877A external-priority patent/TR201002877A2/xx
Application filed by Mahmut Bilgic filed Critical Mahmut Bilgic
Publication of WO2011129788A1 publication Critical patent/WO2011129788A1/fr
Priority to US13/451,838 priority Critical patent/US9345848B2/en
Priority to IN4987DEN2012 priority patent/IN2012DN04987A/en
Priority to US14/695,726 priority patent/US9795750B2/en
Priority to US14/695,739 priority patent/US9795751B2/en
Priority to US15/792,245 priority patent/US10842952B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A61M15/0025—Mouthpieces therefor with caps
    • A61M15/0026—Hinged caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0043—Non-destructive separation of the package, e.g. peeling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A61M15/0046—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
    • A61M15/0051—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged on a tape, e.g. strips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A61M15/0053—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type or way of disposal
    • A61M15/0055—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type or way of disposal the used dosages being coiled
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
    • A61M15/007—Mechanical counters
    • A61M15/0071—Mechanical counters having a display or indicator
    • A61M15/0075—Mechanical counters having a display or indicator on a disc
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
    • A61M15/0081—Locking means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/062—Desiccants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/27—General characteristics of the apparatus preventing use
    • A61M2205/276—General characteristics of the apparatus preventing use preventing unwanted use

Definitions

  • the present invention relates to an inhaler appropriate for delivering the medicament in dry powder form used in the treatment of respiratory diseases, particularly in asthma and chronic obstructive pulmonary disease (COPD).
  • COPD chronic obstructive pulmonary disease
  • the present invention relates to a user- friendly inhaler which is actuated by the rotation of the mouthpiece.
  • inhalers for delivering medicaments utilized in the treatment and prophylaxis of respiratory diseases.
  • Inhalation treatment is the most commonly preferred treatment method in these diseases as the inhalers provide ease of use; the medicaments have rapider onset of time resulting from local administration and they have fewer side effects.
  • Various inhalers have been designed in order to provide effective and sufficient delivery of the medicaments used in the treatment of respiratory diseases, particularly in asthma and chronic obstructive pulmonary disease. These inhalers vary according to their operating mechanisms and the physical form of the medicament to be delivered.
  • the medicament is carried in reservoirs, capsules or blisters packages. It is highly significant to provide the delivery of sufficient amounts of the medicament to the patient since the required amount of the dry powder medicament to be delivered to the patient for each inhalation is very low.
  • most inhalers used for delivering dry powder medicament comprise mouthpiece cover component. This mouthpiece cover component can be used to preserve the mouthpiece, to actuate the device mechanism or for both purposes.
  • the cover In the inhalers actuated by the mouthpiece cover, the cover has to be rotated as required and manually for the device mechanism to operate properly.
  • the mouthpiece cover has to be rotated rapidly for the dry powder medicament to be prepared for inhalation in a short time particularly in the course of a crisis. So as to meet all these requirements, the mouthpiece cover should hold the necessary specifications to be rotated easily. In the case that the mouthpiece cover cannot be rotated comfortably, the patient is distressed as the required active agent cannot be inhaled and the inhalation takes long.
  • the inhaler disclosed in patent numbered WO 2007/012871 is actuated by the rotation of the mouthpiece cover. With the rotation of the cover, both the mouthpiece of the inhaler is exposed and the dry powder medicament to be inhaled becomes ready for inhalation. Therefore, it is essential to move the cover as required for the device mechanism to operate properly. However, it is probable that the cover movement which the patient performs to actuate the inhaler is not efficient enough to enable proper actuation of the inhaler in all cases as the cover does not hold any specifications providing the cover to be easily moved.
  • the cover can be moved easily at all events in the case that one end of the cover which enables the actuation of the inhaler and/or hiding the mouthpiece is carved in an appropriate shape and size.
  • the cover can be easily moved, it becomes possible to execute an effective movement of the cover enough to enable the device to work properly. In this way, an effective inhalation is realized as a result of the inhalation of sufficient amounts of the active agents in each actuation of the device.
  • the present invention relates to an inhaler having an easily rotatable cover which is used for delivery of medicament in dry powder form.
  • An inhaler suitable for delivery of the medicament in dry powder form according to the present invention is characterized in that the front and/or back end of the mouthpiece cover hiding the mouthpiece, which is in contact with the finger while being rotated manually, is carved in the shape of an arc of a circle.
  • the inhaler pertaining to the present invention that is suitable for delivering dry powder medicament is characterized in that the front and/or back end of the mouthpiece cover hiding the mouthpiece, which is in contact with the finger while being rotated manually, is carved in the shape of an arc of a circle of at least 30°.
  • the carved part in the front and/or back end of the mouthpiece cover, which is in contact with the finger while being manually rotated is in the shape of an arc of 30° of a circle which has a radius in the range of 30 mm to 40 mm, preferably in the range of 32.5 mm to 37.5 mm.
  • one end or both ends of the mouthpiece cover of the inhaler pertaining to the present invention can be carved in the specified sizes and structures.
  • the mouthpiece cover matches with the shape of any human finger, and therefore any patient can easily and rapidly rotate the mouthpiece cover hiding the mouthpiece of the inhaler as a result of the fact that the front and/or back end of the rotatable mouthpiece cove, which is in contact with the finger while being manually rotated, is carved in the shape of an arc of at least 30°, preferably in the range of 30° to 120°, most preferably in the range of 30° to 100°.
  • the carved part in the front and/or back end of the mouthpiece cover is in a size to match with the shape of the thumb which is generally used to rotate the mouthpiece cover.
  • the thumb can be placed in this carved part; the cover can be tightly gripped and rotated properly and rapidly.
  • the said carved part in the front and/or back end of the mouthpiece cover is in a size to match with the thumb of any patient, the possibility of accidental backward slip of the mouthpiece cover while being rotated is eliminated. Otherwise, it may take long to rotate the mouthpiece cover as required since it requires skill and attention.
  • the width of the mouthpiece cover and at the same time the width of the carved part in the front and/or back end of the mouthpiece cover is in the range of 10 mm to 20 mm, preferably in the range of 11 mm to 16 mm and this helps the mouthpiece cover be easily rotatable.
  • the carved part in the front and/or back end of the mouthpiece cover enables the inhaler to be actuated rapidly by any patient at any case as its being in a shape and size that matches with the shape of any person's thumb brings the mouthpiece cover ergonomic specifications.
  • the movement of the cover required for the device mechanism to operate properly is executed easily and rapidly as required and the sufficient amount of the active agent becomes ready for inhalation in response to each actuation of the device in the inhalers that are actuated by the mouthpiece cover.
  • the inhalation is performed effectively in a short time, the patient is provided with a sense of well being both psychologically and physiologically.
  • the mouthpiece cover having a carved part of said sizes and specifications in its front and/or back end is preferably utilized in inhalers that are actuated by mouthpiece covers.
  • the inhaler pertaining to the present invention is preferably actuated by the cover and it is appropriate for delivering medicament in dry powder form.
  • the inhaler according to the present invention is an easy-grip manual device which is appropriate for delivering medicament in dry powder form.
  • the inhaler pertaining to the present invention preferably comprises peelable blister package. According to this, there is a gear mechanism actuated by the mouthpiece cover in the inhaler pertaining to the present invention.
  • the gear mechanism actuated by the rotation of the mouthpiece cover provides the blister package to be indexed and the blister pocket containing one dose of dry powder medicament to be opened.
  • the components comprising the inhaler pertaining to the present invention enables the inhaler to work properly.
  • the housing of the device pertaining to the present invention has been designed such that each component of the blister package and the gear mechanism is situated accurately and works harmoniously.
  • the housing also comprise the beak which enables the blister package to be peeled and the manifold through which the dry powder medicament in the open blister passes before reaching the mouthpiece during the inhalation.
  • the housing can be in any appropriate shape while it is preferably elliptic or circular.
  • the upper and the lower housing members interlock with each other and enclose the housing in order to keep the housing and the gear mechanism fixed together.
  • the mouthpiece cover hiding the mouthpiece is rotated by being slid on the upper and lower housing members.
  • the upper and the lower housing members can be in any appropriate shape or size which provides ease of use.
  • each connection point of the mouthpiece cover there is a stabilizing resilient cover.
  • the extensions under the stabilizing resilient covers pass through the holes on the upper or the lower housing member according to the position of the connection point and provide the stabilizing resilient covers that they connect with to remain stable.
  • the rotation of the mouthpiece cover is prevented from both sides as the pawl under each of the stabilizing resilient covers in both sides of the device interlocks with the mouthpiece cover.
  • the resilient parts of each stabilizing resilient cover which matches with the shape of the fingers are pressed on for raising the pawls and releasing the mouthpiece cover in order to move the mouthpiece cover which actuates the device.
  • the mouthpiece cover can easily be rotated when the resilient parts of each stabilizing resilient cover on both sides of the device which match with the shape of the fingers are pressed on.
  • the resilient parts of the stabilizing resilient covers are not pressed on, the pawls under the stabilizing resilient covers do not allow the mouthpiece cover to move in any circumstances.
  • the mouthpiece cover that actuates the device can solely be in two positions.
  • the mouthpiece cover should be moved from the first position to the second position.
  • the mouthpiece cover When the mouthpiece cover is in the first position, it leans on the protruding part in one end of the rotational path.
  • the mouthpiece is completely hidden when the mouthpiece cover is in the first position and the device is on standby mode.
  • the mouthpiece cover When the mouthpiece cover is in the second position, it leans on the protruding part on the other end of the rotational path and one dose of the medicament in dry powder form is prepared for inhalation upon the actuation of the device.
  • Each gear of the gear mechanism in the device according to the present invention is directly or indirectly engages with each other.
  • the constant-angle rotational movement of the mouthpiece cover is transmitted to the indexing ratchet wheel which engages with the drive gear owing to the connection made via the side covers between the mouthpiece cover of the inhaler and the drive gear.
  • the indexing ratchet gear which interlocks with the indexing wheel from inside thanks to its arms cause the indexing wheel to rotate.
  • the blister package is indexed and it is peeled by the beak comprised in the housing.
  • the indexing wheel engages with the winding wheel gear and the pinion gear, these gears rotate as well upon the rotation of the indexing wheel.
  • the rotation of the winding wheel gear causes the winding wheel to move and lid sheet of the blister package coils on the winding wheel tightly.
  • Pinion gear engages with the base gear while the small gear under the base gear engages with the counter gear.
  • the rotation of the indexing wheel is transmitted to the base gear via the pinion gear.
  • the rotation of the base gear causes the counter gear to move as the small gear under the base gear synchronizes with the base gear.
  • the counter gear which rotates in each actuation of the inhaler causes the number of the unused blister pockets that can be seen through the display aperture on an appropriate spot of the inhaler pertaining to the present invention to be incremented.
  • the blister package carries the medicament in dry powder form in one-dose portions and it is preferably a blister strip and it is preferably peelable.
  • the blister pockets comprised in the blister package are spaced in equal intervals and each of them carries one dose of the medicament in dry powder form. While the blister package is indexed on the indexing wheel, the beak on the housing peels the blister. Therefore, one dose dry powder medicament becomes ready for inhalation after the blister package is peeled to be opened in each actuation of the device.
  • the blister is opened as a result of the actuation of the device after the mouthpiece is moved with the help of the carved part in its front and/or back end and the opened blister is situated immediately under the manifold.
  • One end of the manifold communicates with the opened blister while its other end communicates with the mouthpiece.
  • the mouthpiece is designed to fit the mouth for the patient to comfortably inhale the medicament in dry powder form.
  • the mouthpiece can be in any suitable shape and size as well as being fixed or movable. Furthermore, it could be attached or unattached to the upper and/or the lower cover.
  • Each component of the device pertaining to the present invention can be made of any appropriate substance while it is preferably made of plastics.
  • plastic substances are selected from a group comprising styrene-acrylonitrile, polyoxymethylene (it is generally named as POM and it is also known as polyacetal or polyformaldehyde), acrylic- polymethylmetacrylate, cellulose acetate, polyetheretherketone, polyvinyl choloride, polyethylene, polypropylene, acrylonitrile butadiene styrene, polycarbonate, polyamide, polystyrene, polyurathane or fluoropolymer types while it is more preferably polyoxymethylene.
  • the components made of plastics can be produced by methods such as injection molding. Furthermore, each component of the device can be in any appropriate color.
  • the lid and the base sheets constituting the blister package preferably consist of a plurality of layers. Each of these layers are preferably chosen from a group comprising polymeric layers that are made of various polymeric substances; aluminum foil and fluoropolymer film.
  • the lid and base sheets composing the blister package are sealed very tightly by at least one of the methods comprising cold formed bonding, hot metal bonding, hot metal welding, radio frequency welding, laser welding or ultrasonic welding in order to provide impermeability, more preferably by cold formed bonding method. Since these cold formed bonding methods can be carried out at lower temperatures than hot sealing methods, they are the most appropriate methods to use in the case that the medicament carried in the blister is heat sensitive.
  • Fluoropolymer film is a polymeric film which is used in blister packs and provides excellent moisture barrier. This chemically inert polymeric film does not cause any change in the taste of the formulation when it is in contact with the dry powder formulation. In addition, it easily constitutes a layered structure with the other polymeric layers which are composed of various polymers. It is appropriate to be transacted with heat.
  • At least one of the polymeric layers comprises at least one desiccant agent including silica gel, zeolite, alumina, bauxite, anhydrous calcium sulfate, activated carbon and clay which has the property of water absorption in order to decrease gas and moisture permeability of the layer.
  • desiccant agent including silica gel, zeolite, alumina, bauxite, anhydrous calcium sulfate, activated carbon and clay which has the property of water absorption in order to decrease gas and moisture permeability of the layer.
  • the thickness of the aluminum foil in the lid and the base sheets of the blister package are preferably chosen to be in the range of 5 to 80 ⁇ , more preferably in the range of 15 to 65 ⁇ .
  • the polymeric layers in the lid and the base sheets of the blister pack are made of the same or different polymers.
  • the thickness of these polymeric layers varies according to the type of the polymeric substance used and its properties while they are preferably in the range of 5 to 100 ⁇ , more preferably in the range of 15 to 60 ⁇ .
  • the polymers composing the polymeric layer are preferably selected from thermoplastics such as polyethylene, polypropylene, polystyrene, polyolefin, polyamide, polyvinyl chloride, polyurethane or synthetic polymers.
  • the blister pockets in the blister package can be in any appropriate shape.
  • the plurality of blister pockets spaced at equal intervals on the base sheet of the blister package can be in the same or different shape, structure and volume.
  • Figure 1 is a perspective view of an inhaler according to the inhaler described in the present invention.
  • Figure 2 is an exploded view of the inhaler pertaining to the invention
  • Figure 3 is a perspective view of the blister pack for use with the inhaler pertaining to the invention.
  • Figure 4a is a perspective view of the mouthpiece cover of the inhaler pertaining to the present invention.
  • Figure 4b is an exploded view of the communication between the mouthpiece cover, the drive gear and the stabilizing resilient covers in the inhaler pertaining to the invention
  • Figure 4c is a cross-sectional view of the communication between the mouthpiece cover, the drive gear and the stabilizing resilient covers in the inhaler pertaining to the invention
  • Figure 4d is a cross-sectional view of the communication between the mouthpiece cover, the drive gear and the stabilizing resilient covers in the inhaler pertaining to the invention
  • Figure 5a is front view of the inhaler pertaining to the present invention
  • Figure 5b is a lateral view of the inhaler pertaining to the present invention
  • Figure 6 is a cross-sectional view of the engagement of the gears composing the gear mechanism with each other in the inhaler pertaining to the present invention
  • Figure 7 is a cross-sectional view of the engagement of the gears composing the gear mechanism with each other in the inhaler pertaining to the present invention
  • Figure 8 is a cross-sectional view of the blister package delaminating in course of operation of the inhaler pertaining to the present invention.
  • the inhaler (1) pertaining to the present invention comprises a gear mechanism situated in the housing (10) between the upper housing member (4a) and the lower housing member (4b) in order to enable the inhalation of the dry powder medicament carried in a blister package (15) as displayed in figures 1 and 2.
  • Each component of the inhaler (1) is positioned at appropriate spots of the device to guarantee their working properly and accurately.
  • the inhaler (1) pertaining to the present invention shown in Figure 1 is ready for inhalation.
  • the mouthpiece cover (2) is in the second position and the mouthpiece (14) is entirely exposed.
  • the mouthpiece cover (2) has to be rotated by holding on the carved part (2a) on one end of the mouthpiece cover (2) in order to switch to the second position from the first position wherein the mouthpiece is completely covered.
  • the mouthpiece (14) is completely exposed when the mouthpiece cover (2) is switched to the second position from the first position and the gear mechanism is triggered by the drive gear (12).
  • the drive gear (12) precisely transmits the movement of the mouthpiece cover (2) to the indexing ratchet wheel (3).
  • the indexing wheel (8) which engages with the indexing ratchet wheel (3) enables the blister package (15) shown in figure 3 to be indexed.
  • the blister pockets (15a) composing the blister package are received in the recesses (8a) on the indexing wheel and the blister package (15) is indexed when the indexing wheel (8) rotates.
  • shapes of the recesses (8a) on the indexing wheel (8) have been designed to match the shapes of the blister pockets (15) composing the blister package (15) for the blister package to be indexed properly.
  • the blister package (15) shown in figure 3 is composed of the lid sheet (15b) which provides impermeability and the base sheet (15c) on which the blister pockets (15a) are spaced at equal intervals.
  • Each blister pocket contains medicament in dry powder form comprising one or more active agents.
  • the rotational movement that the mouthpiece cover (2) of the device executes while switching from the first position to the second is transmitted to the indexing ratchet wheel (3) via the drive gear (12) that the mouthpiece cover (2) engages with.
  • arms (3 a) of the indexing ratchet wheel interlocks with protrusions inside the indexing wheel (8) and rotates the indexing wheel (8) unidirectionally. Therefore, the blister package (15) is indexed forward while the indexing wheel (8a) rotates as the blister pockets (15a) composing the blister package (15) are received in the recesses (8a) of the indexing wheel.
  • the beak (16) in the housing (10) provides the blister package (15) to be peeled while the blister package (15) is indexed and provides one blister pocket (15a) to be opened in response to each actuation of the device (1).
  • the winding wheel gear (6) which is another component of the gear mechanism, engages with the indexing wheel (8) as displayed in figure 2.
  • the mechanism gear (5) that interlocks the winding wheel (13) from inside has arms (5a) to interlock with the interior teeth of the winding wheel gear (6).
  • the indexing wheel (12) rotates the winding wheel gear (6)
  • the winding wheel rotates unidirectionally owing to the arms of the mechanism gear (5 a) which interlock with the interior teeth of the winding wheel gear (6) and the lid sheet (15b) which is peeled away while the blister package is indexed is tightly coiled on the wings (13a) of the winding wheel.
  • the base sheet (15c) of the blister package (15) where the blister pockets are spaced is accumulated in a separate part (18a) of the device.
  • the mouthpiece cover (2) that engages with the gear mechanism of the inhaler and provides to actuate the device is illustrated in figure 4a.
  • One end (2a) of the mouthpiece cover is carved such that it can easily be rotated.
  • the mouthpiece cover (2) is connected with the gear mechanism in both sides of the device (1) via the connection points (29, 30).
  • the drive gear (12) interconnects with the connection points (30, 29) of the mouthpiece cover via the side covers (31a, 31c), as it can clearly be seen in figures 4b, 4c and 4d illustrating the communication between the mouthpiece cover (2), the drive gear (12), the side covers (31a, 31c) and the stabilizing resilient covers (32, 33).
  • Both ends (12a; 12b) of the drive gear are carved such that the end of the side cover that engages with it can interlock.
  • Each end (3 Id; 3 lb) of the side covers passes through one of the connection points (29; 30) of the mouthpiece cover and it is fixed in the carved part (12b; 12a) in one end of the drive gear (12b; 12a). Therefore, the mouthpiece cover (2) and the drive gear (12) synchronize.
  • the mouthpiece cover (2) can be rotated by holding from the front end (2a) or back end (2b) of its with the help of the thumb. Therefore, the front end (2a) or the back end (2b) of the mouthpiece cover (2) is in contact with the patient's finger while it is moved manually. According to figure 5a, only the front end (2a) of the mouthpiece cover (2) of the inhaler is carved such that it matches with the shape of the thumb so as to provide the mouthpiece cover (2) to be rotated easily and rapidly while the back end (2b) of the mouthpiece cover is not carved. However, it is probable that both the front end (2a) and the back end (2b) of the mouthpiece cover are carved.
  • the shape of the carved part in the front end (2a) of the mouthpiece cover resembles to the shape of the thumb for the thumb to be placed in this carved part exactly in order to rotate the mouthpiece cover.
  • the carved part of the front end (2a) of the mouthpiece cover illustrated in figure 5a is in the shape of the arc of the circle which has a radius (R) in the range of 30 mm to 40 mm, preferably in the range of 32.5 mm to 37.5 mm.
  • the carved part (2a) in the front end of the mouthpiece of the device shown in figure 5a is in the shape of the arc of 45° of said circle.
  • Dl distance is in the range of 10 mm to 20 mm, preferably in the range of 11 mm to 16 mm.
  • stabilizing resilient cover (33; 32) on each connection point (29; 30) of the mouthpiece and on each side cover (31c; 31a) as displayed in figures 4b-4d.
  • These pawls (32a, 33a) under the stabilizing resilient covers interlock with the mouthpiece cover (2) and hinder its movement.
  • each stabilizing resilient cover illustrated in figures 4b-4d are pressed on for raising the pawls (32a, 33a) and releasing the mouthpiece cover (2) in order to actuate the gear mechanism of the device to prepare one dose of dry powder medicament before inhalation. Therefore, the gear mechanism of the device is actuated and one blister pocket (15a) is opened for one dose of the dry powder medicament to be ready for inhalation when the resilient parts (32d, 33 d) of the stabilizing resilient covers are pressed on and the mouthpiece cover (2) is switched from the first position to the second position simultaneously.
  • the air entering the device upon the inhalation of the device passes through the manifold (20) and reaches the opened blister pocket; entrains one dose of dry powder medicament in the opened blister pocket to the manifold (20); passes the dry powder medicament through the manifold (20) and the mouthpiece (14) respectively, then provides the medicament to be delivered to the patient.
  • the indexing wheel (8) which synchronizes with the indexing ratchet wheel (3) is engaged with the winding wheel gear (6) and the pinion gear (11) and the rotation of the indexing wheel (8) causes the pimon gear (1 1) and the winding wheel gear (6) to rotate.
  • both the peeled lid sheet (15b) of the blister package (15) which is indexed by the rotation of the indexing wheel (8) is tightly coiled on the winding wheel (13) engaging with the winding wheel gear (6) and also the counter wheel (9) is provided to be moved by the pinion gear (11) and the base gear (7) as a result of the rotation of the indexing wheel (8).
  • the gear which directly engages with the counter gear (9) is the small gear (7a) that is under the base gear (7) as attached. Therefore, the movement transmitted to the base gear (7) via the pinion gear (11) is transmitted to the counter gear (9) by the small gear (7a) and the counter gear (9) is rotated.
  • the lid sheet (15b) of the blister package (15) which is peeled away by the beak (16) and the base sheet (15c) are enclosed in separate compartments.
  • the lid sheet (15b) that provides impermeability is indexed over the beak (16) and tightly coiled on the wings (13a) of the winding wheel.
  • the base sheet (15c) of the blister package (15) where the blister pockets (15a) each of which carries one dose of the dry powder medicament are spaced is accumulated in the partitioned compartment (18a) of the housing (10).
  • one dose of the dry powder medicament which is prepared for inhalation after one blister pocket (15a) is opened and the air entering the device through the air inlet (22) upon the inhalation of the patient provides to deliver one dose of the dry powder medicament to the patient by entraining it from the blister pocket (15a) to the mouthpiece (14).
  • the medicament in dry powder form which is stored in blister cavities is manufactured according to the prior art.
  • the particle sizes of the active agents comprised in the dry powder medicament are smaller than 20 ⁇ , preferably smaller than 10 ⁇ .
  • the inhaler pertaining to the present invention has been designed so as to deliver the dry powder medicament used in monotherapy or combined therapy.
  • monotherapy refers to inhalation treatments in which dry powder medicaments comprising a single active ' agent are used whereas the term “combined therapy” refers to inhalation treatments in which dry powder medicaments comprising more than one active agents are use used.
  • the dry powder medicament delivered via the device pertaining to the present invention comprises at least one excipient in addition to the active agent or agents.
  • excipients are generally chosen from a group comprising monosaccharides (glucose, arabinose, etc.), disaccharides (lactose, saccharose, maltose, etc.), oligo- and polysaccharides (dextran, etc.), polyalcohols (sorbite, mannite, xylite), salts (sodium chloride, calcium carbonate, etc.) or combinations thereof.
  • the medicament in dry powder form comprises lactose as the excipient.
  • the medicament in dry powder form comprises fine or coarse excipients particles preferably having various particle size ranges in order to deliver the required amount to the lungs.
  • the active agent or the active agents comprised in the dry powder medicament which is stored in blister packages used in the device pertaining to the present invention can be selected from a group comprising cromolyns, anti-infectives, antihistamines, steroids, anti- inflammatories, bronchodilators, leukotirene inhibitors, PDE IV inhibitors, antitussives, diuretics, anticholinergics, hormones, xanthines and pharmaceutically acceptable combinations thereof.
  • the active agent comprised in the medicament in dry powder form delivered via the inhaler pertaining to the present invention is preferably selected from a group comprising tiotropium, oxitropium, flutropium, ipratropium, glicopironium, flunisolid, beclomethasone, budesonide, fluticasone, mometasone, ciclesonide, rofleponide, dexamethasone, montelukast, methylcyclopropane acetic acid, sodium cromoglicat, nedocromil sodium, Npropylene, teophylline, roflumilast, ariflo (cilomilast), salmeterol, salbutamol, formoterol, terbutaline, carmoterol, indacaterol, cetirizine, levocetirizine, efletirizine, fexofenadine and their racemates, free base, enantiomers or diastereomers and
  • the device pertaining to the present invention is used in the administration of the medicament in dry powder form which is utilized in the treatment of many respiratory diseases, particularly in asthma, chronic obstructive pulmonary disorder (COPD) and allergic rhinitis.
  • the respiratory diseases include, but not restricted to, allergic or non-allergic asthma at any phases, acute lung injury (ALI), acute respiratory distress syndrome (ARDS), exacerbation of airways hyperactivity, bronchiectasis, chronic obstructive pulmonary including emphysema and chronic bronchitis, airways or lung diseases (COPD, COAD or COLD), pneumoconiosis, aluminosis, anthracosis, asbestosis, chalicosis, ptilosis, siderosis, silicosis, tabacosis and byssinosis.
  • the device pertaining to the invention can be used in prophylactic or symptomatic treatment.
  • the medicament in dry powder form which is preferably used in the symptom

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

La présente invention concerne un inhalateur d'utilisation facile et rapide, qui comprend un emballage-coque se prêtant à une administration du médicament sous forme de poudre sèche, pour le traitement de maladies respiratoires, notamment l'asthme, la maladie pulmonaire obstructive chronique (MPOC) et la rhinite allergique.
PCT/TR2011/000088 2009-10-20 2011-04-13 Inhalateur à poudre sèche d'utilisation facile WO2011129788A1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US13/451,838 US9345848B2 (en) 2009-10-20 2012-04-20 Dry powder inhaler
IN4987DEN2012 IN2012DN04987A (fr) 2010-04-13 2012-06-06
US14/695,726 US9795750B2 (en) 2009-10-20 2015-04-24 Dry powder inhaler
US14/695,739 US9795751B2 (en) 2009-10-20 2015-04-24 Dry powder inhaler
US15/792,245 US10842952B2 (en) 2009-10-20 2017-10-24 Dry powder inhaler

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
TR2010/02877A TR201002877A2 (tr) 2010-04-13 2010-04-13 Blister ambalaj içeren inhalasyon cihazı
TR2010/02877 2010-04-13
TR201003091 2010-04-20
TR2010/03091 2010-04-20
TR201004308 2010-05-28
TR2010/04308 2010-05-28

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2011/000087 Continuation-In-Part WO2011129787A1 (fr) 2009-10-20 2011-04-13 Bouton d'embout buccal pour inhalateur à poudre sèche

Related Child Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2011/000085 Continuation-In-Part WO2011129785A1 (fr) 2009-10-20 2011-04-13 Bouton d'embout buccal pour inhalateur à poudre sèche

Publications (1)

Publication Number Publication Date
WO2011129788A1 true WO2011129788A1 (fr) 2011-10-20

Family

ID=44798916

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2011/000088 WO2011129788A1 (fr) 2009-10-20 2011-04-13 Inhalateur à poudre sèche d'utilisation facile

Country Status (2)

Country Link
IN (1) IN2012DN04987A (fr)
WO (1) WO2011129788A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2666504A1 (fr) * 2012-05-25 2013-11-27 Arven Ilac Sanayi Ve Ticaret A.S. Mécanisme d'avancement de blister comprenant une plaque d'actionneur
EP2666501A1 (fr) * 2012-05-25 2013-11-27 Arven Ilac Sanayi Ve Ticaret A.S. Inhalateur doté d'un corps interne avec canal d'air
USD733287S1 (en) 2011-04-13 2015-06-30 Mahmut Bilgic Dry powder inhaler
USD744087S1 (en) 2013-10-01 2015-11-24 Mahmut Bilgic Dry powder inhaler
US9956362B2 (en) 2012-05-25 2018-05-01 Arven Ilac Saniyi ve Ticaret A.S. Trigger mechanism for inhaler device
US10842952B2 (en) 2009-10-20 2020-11-24 Sima Patent Ve Lisanslama Hizmetleri Ltd. Sti. Dry powder inhaler

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003095010A2 (fr) * 2002-05-10 2003-11-20 Oriel Therapeutics, Inc. Inhalateurs de poudre seche, dispositifs a emballage-coque correspondants et procedes correspondants de distribution de poudre seche et de fabrication d'emballages-coques
WO2007012871A1 (fr) 2005-07-28 2007-02-01 Glaxo Group Limited Distributeur de médicaments
GB2447560A (en) * 2007-03-14 2008-09-17 Cambridge Consultants Inhaler with actuating mouthpiece cover
US20080308102A1 (en) * 2005-12-12 2008-12-18 Glaxo Group Limited Manifold for Use in Medicament Dispenser
WO2009139731A1 (fr) * 2008-05-16 2009-11-19 Bilgic Mahmut Mécanisme comprenant une bande alvéolée thermoformée
US20100059052A1 (en) * 2006-11-15 2010-03-11 Glaxo Group Limited Sheet driver for use in a drug dispenser

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003095010A2 (fr) * 2002-05-10 2003-11-20 Oriel Therapeutics, Inc. Inhalateurs de poudre seche, dispositifs a emballage-coque correspondants et procedes correspondants de distribution de poudre seche et de fabrication d'emballages-coques
WO2007012871A1 (fr) 2005-07-28 2007-02-01 Glaxo Group Limited Distributeur de médicaments
US20080308102A1 (en) * 2005-12-12 2008-12-18 Glaxo Group Limited Manifold for Use in Medicament Dispenser
US20100059052A1 (en) * 2006-11-15 2010-03-11 Glaxo Group Limited Sheet driver for use in a drug dispenser
GB2447560A (en) * 2007-03-14 2008-09-17 Cambridge Consultants Inhaler with actuating mouthpiece cover
WO2009139731A1 (fr) * 2008-05-16 2009-11-19 Bilgic Mahmut Mécanisme comprenant une bande alvéolée thermoformée

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10842952B2 (en) 2009-10-20 2020-11-24 Sima Patent Ve Lisanslama Hizmetleri Ltd. Sti. Dry powder inhaler
USD733287S1 (en) 2011-04-13 2015-06-30 Mahmut Bilgic Dry powder inhaler
EP2666504A1 (fr) * 2012-05-25 2013-11-27 Arven Ilac Sanayi Ve Ticaret A.S. Mécanisme d'avancement de blister comprenant une plaque d'actionneur
EP2666501A1 (fr) * 2012-05-25 2013-11-27 Arven Ilac Sanayi Ve Ticaret A.S. Inhalateur doté d'un corps interne avec canal d'air
WO2013176640A1 (fr) * 2012-05-25 2013-11-28 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalateur comprenant un corps interne doté d'un canal d'air
WO2013176643A1 (fr) * 2012-05-25 2013-11-28 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Mécanisme d'avancement de blister comprenant une plaque d'actionnement
JP2015518744A (ja) * 2012-05-25 2015-07-06 アーヴェン イラチュ サナイ ヴェティヂャレット エー． エス．Ａｒｖｅｎ Ｉｌａｃ Ｓａｎａｙｉ Ｖｅ Ｔｉｃａｒｅｔ Ａ．Ｓ． 作動板を備えるブリスター前進機構
EA028957B1 (ru) * 2012-05-25 2018-01-31 Арвен Айлак Санайи Ве Тиджарет А.С. Механизм для продвижения блистера, содержащий приводную пластину
US9956362B2 (en) 2012-05-25 2018-05-01 Arven Ilac Saniyi ve Ticaret A.S. Trigger mechanism for inhaler device
US10207067B2 (en) 2012-05-25 2019-02-19 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Blister advancement mechanism comprising an actuator plate
USD744087S1 (en) 2013-10-01 2015-11-24 Mahmut Bilgic Dry powder inhaler

Also Published As

Publication number Publication date
IN2012DN04987A (fr) 2015-10-02

Similar Documents

Publication Publication Date Title
US10842952B2 (en) Dry powder inhaler
EP2566546B1 (fr) Bouton d'embout buccal pour inhalateur à poudre sèche
EP2566549B1 (fr) Bouton d'embout buccal pour inhalateur à poudre sèche
EP2566551B1 (fr) Inhalateur
WO2011129788A1 (fr) Inhalateur à poudre sèche d'utilisation facile
EP2566547B1 (fr) Bouton d'embout buccal pour inhalateur à poudre sèche
EP2566548B1 (fr) Inhalateur comprenant un emballage-coque
WO2011129787A1 (fr) Bouton d'embout buccal pour inhalateur à poudre sèche
EP2566550A1 (fr) Inhalateur créant une turbulence
JP5873477B2 (ja) 乾燥粉末形態の薬剤の送達に使用する吸入器

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11729490

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 4987/DELNP/2012

Country of ref document: IN

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11729490

Country of ref document: EP

Kind code of ref document: A1